Sep 2, 2026 07:00AM
Aug 31, 2026 07:00AM
Aug 31, 2026 07:00AM
Aug 11, 2026 06:57AM
Aug 10, 2026 07:00AM
Jul 16, 2026 06:47AM
Jul 15, 2026 07:00AM FDA accepts Axsome drug application for cataplexy treatment
Jul 15, 2026 07:00AM
Jul 14, 2026 07:00AM
Jul 7, 2026 07:00AM
Jul 7, 2026 07:00AM
Jun 26, 2026 07:00AM
Jun 26, 2026 07:00AM
Jun 18, 2026 07:00AM Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness Month
Jun 18, 2026 07:00AM
Jun 15, 2026 07:02AM
Jun 15, 2026 07:00AM
Jun 4, 2026 07:00AM
Jun 4, 2026 06:40AM
Jun 3, 2026 07:04AM
Jun 3, 2026 07:00AM Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation
Jun 1, 2026 07:03AM
Jun 1, 2026 07:00AM
May 27, 2026 07:00AM
May 26, 2026 07:00AM
May 7, 2026 07:00AM
May 5, 2026 07:00AM
May 4, 2026 01:15PM Axsome Therapeutics (AXSM) PT Raised to $260 at Guggenheim
May 4, 2026 07:33AM
May 4, 2026 07:00AM
May 1, 2026 07:15AM
May 1, 2026 07:15AM
Apr 30, 2026 05:15PM
Apr 30, 2026 02:06PM
Apr 30, 2026 02:06PM Axsome Therapeutics Announces FDA Approval of AUVELITY® (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease
Apr 10, 2026 09:31AM
Apr 8, 2026 07:00AM
Apr 1, 2026 05:41PM
Apr 1, 2026 07:00AM
Apr 1, 2026 07:00AM
Mar 25, 2026 06:07AM
Feb 25, 2026 07:00AM Axsome Therapeutics to Participate in Upcoming Investor Conferences
Feb 24, 2026 07:00AM
Feb 24, 2026 07:00AM
Feb 23, 2026 12:17PM
Feb 23, 2026 07:00AM
Feb 18, 2026 07:00AM
Feb 17, 2026 07:00AM
Jan 27, 2026 07:00AM Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 23
Jan 15, 2026 07:00AM

330,085 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All